Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies

Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies

US Patent 10117881 · Granted Nov 6, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel2024
Prevention of drug-induced atrio-ventricular block2023
Suppression of cytokine release and cytokine storm2020
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rect2020
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel2020
Treatment for glioblastoma2019
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that2019
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rect2019
Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel2019
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drug2019
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that2019
Liposomal curcumin for treatment of diseases2018